Gender-dependent effects of metformin on vaspin and adiponectin in type 2 diabetes patients: a randomized clinical trial.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme

Volumn 45, Issue 4, 2013, Pages 319-325

  Esteghamati, A ^a   Mousavizadeh, M ^a   Noshad, S ^a   Zandieh, A ^a   Zarei, H ^a   Nakhjavani, M ^a  

^a not available ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; ANTIDIABETIC AGENT; METFORMIN; SERINE PROTEINASE INHIBITOR; SERPINA12 PROTEIN, HUMAN;

ARTICLE; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL; SEXUAL DEVELOPMENT;

ADIPONECTIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; METFORMIN; MIDDLE AGED; SERPINS; SEX CHARACTERISTICS;

EID: 85027943681     PISSN: None     EISSN: 14394286     Source Type: None    
DOI: 10.1055/s-0032-1330008     Document Type: Article

References (0)